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eativecommons.org/licenses/by-nc-Summary A 51-year-old man was referred to our clinic for recurrent obstructive jaundice
and underwent pylorus-preserving pancreaticoduodenectomy for a suspected malignancy.
The pathology showed immunoglobulin G4 positive plasma cell infiltrated at the pancreas
and the gallbladder. We discuss the cost-effectiveness of serum immunoglobulin G4 level prior
to arranging for a pancreaticoduodenectomy, which would reduce the possibility of surgical
complications as well as costs.
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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Immunoglobulin G4 (IgG4)-related pancreatitis, also called
sclerosing pancreatitis, lymphoplasmacytic sclerosingf Gastroenterology, Depart-
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nd/4.0/).pancreatitis, or autoimmune pancreatitis, is associated
with serum IgG4 level and tissue infiltration of IgG4-positive
plasma cells [1]. Typically, IgG4-related pancreatitis clini-
cally presents with chronic inflammation of the pancreas,
tumefactive lesions, and obstructive jaundice, which is
easily confused with malignancy. IgG4-related pancreatitis
is considered a systemic disease, and its extrapancreatic
involvement has been recognized since 2003 [2]. In general,
the treatment of IgG4-related disease begins with steroids;
subsequently, disease-modifying antirheumatic drugs are
administered to patients with remission and maintenance, The Digestive Endoscopy Society of Taiwan and Taiwan Association
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Figure 2 Cholangiopancreatography shows absence of distal
common bile duct (CBD).
Immunoglobulin G4-related disease 29statuses, and rituximab is used to treat recurrent or re-
fractory disease [3].
Case report
A 51-year-old Taiwanese man was referred to our clinic
for recurrent obstructive jaundice. The patient’s aspar-
tate aminotransferase, alanine aminotransferase,
and total bilirubin levels had risen intermittently for 6
months.
He had a history of benign prostatic hyperplasia that was
not controlled medically, but had no history of major oper-
ations or allergies. The patient smoked one and a half packs
of cigarettes per day for > 20 years, quit drinking alcohol 10
years prior, and socially chewed betel nuts. He is a judo
coach who experiences frequent abdominal contusions.
Physical examinations revealed mild icteric sclera, a birth
mark approximately 3 cm in size in the right upper quadrant
of the abdomen, and no abdominal tenderness, rebounding
pains, or Murphy’s sign. In a review of systems, the patient
complained of anorexia, fatigue, nausea, vomiting, itchy
skin, and weight loss (from 79 kg to 68.2 kg in the past 6
months). Magnetic resonance (MR) cholangiopancreatog-
raphy was scheduled while the patient was hospitalized and
revealed distal common bile duct (CBD) obstruction (Fig. 1).
In addition, the patient received endoscopic retrograde
cholangiopancreatography, but cannulation of the ampulla
of Vater failed initially. Fistulotomy was performed by
inserting a stent into the CBD. The cholangiography revealed
an absence of distal CBD (Fig. 2). Based on the tentative
impression of stricture of distal CBD with obstructive jaun-
dice, pylorus-preserving pancreaticoduodenectomy was ar-
ranged to treat a possible malignancy.
An indurate mass approximately 4 cm in size was
intraoperatively observed over the pancreatic head,
causing distal CBD obstruction and enlarged lymph nodes
over Station 8A. The pathology showed prominent scle-
rosing fibrosis with marked lymphoplasmacytic cell infil-
tration in the pancreas, CBD, and gallbladder as well as
reactive hyperplasia of the lymph nodes. The immuno-
histochemical stains showed that infiltrated plasma cells
were CD138 and IgG4 positive, proliferative small bile
ducts were CK7 positive, no P53 overexpression occurred,Figure 1 Recombinant MR image showing mild dilatation of
both lobes’ IHDs, CHD, and CBD, with abrupt luminal narrowing
over the distal CBD. CBDZ common bile duct; CHDZ common
hepatic duct; IHD Z intrahepatic duct; MR Z magnetic
resonance.and Ki-67 mildly increased. The final diagnosis was IgG4-
related disease with pancreatitis, cholangitis, and
cholecystitis.Discussion
The patient received pylorus-preserving pan-
creaticoduodenectomy for obstructive jaundice of an un-
known cause with a possibility of malignancy. Although no
complication occurred because of surgery, the operation
could have been avoided if we had confirmed the diagnosis
preoperatively. In Taiwan, receiving a test of serum IgG4
levels through the National Health Insurance costs NT$400
(approximately US$13.50). Approximately 2.5% of pan-
creaticoduodenectomies reveal IgG4-related pancreatitis
rather than the suspected malignancy [4e6]. Each diagnosis
from serum IgG4 screen costs NT$16,000 (approximately
US$540.70); by contrast, pancreaticoduodenectomy costs
NT$45,670 (approximately US$1543.40). In a review of
image findings, focal (24e36%) or diffused (32e48%)
parenchymal enlargement of the pancreas was observed on
both computed tomography (CT) and MR images [7,8].
Approximately 14e48% of patients with IgG4-related
pancreatitis presented with a capsule-like rim around the
pancreas, which is specific to IgG4-related pancreatitis
[7e9]. However, this sign was not observed in the image
study of our patient. The capsule-like rim yielded low
attenuation on contrast-enhanced CT images and hypo-
intense on both T1- and T2-weighted dynamic MR images
with delay enhancement [9]. The capsule-like rim may be a
peripancreatic extension of the characteristic inflamma-
tory cell infiltration [9]. For pancreatic malignancy or IgG4-
related disease, CT or MR imaging, serology (serum IgG4 and
Ca19-9), the involvement of other organs, pancreatic core
biopsy, and steroid diagnostic therapy should be considered
prior to a surgical resection [10]. Hence, distinguishing
IgG4-related disease, which can be treated with steroids
rather than surgery, from malignancy early reduces the risk
of operation-related morbidity and mortality.
For patients with recurrent obstructive jaundice, phy-
sicians should assess CT or MR images and conduct serology
30 Y.-H. Chiu et al.studies of liver and pancreatic function as well as IgG4.
Furthermore, a pancreatic core biopsy can be performed
preoperatively to confirm the diagnosis. The aforemen-
tioned examination tool facilitates reducing unnecessary
procedures performed to treat benign diseases and reduces
the possibility of surgical complications as well as costs.
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